New Key Statistics Module, Z-Score and F-Score
OTCPK:CPHGF Key Ratios
Market Cap $ M | 799.78 |
Enterprise Value $ M | 413.11 |
P/E(ttm) | 6.69 |
PE Ratio without NRI | 6.62 |
Forward PE Ratio | 6.36 |
Price/Book | 1.56 |
Price/Sales | 2.04 |
Price/Free Cash Flow | 6.69 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.40 |
Revenue (TTM) $ M | 380.00 |
EPS (TTM) $ | 0.14 |
Beneish M-Score | -2.54 |
10-y EBITDA Growth Rate % | 14.30 |
5-y EBITDA Growth Rate % | 18.60 |
y-y EBITDA Growth Rate % | 10.40 |
EV-to-EBIT | 3.13 |
EV-to-EBITDA | 3.13 |
PEG | 0.36 |
Shares Outstanding M | 825.89 |
Net Margin (%) | 30.53 |
Operating Margin % | 32.39 |
Pre-tax Margin (%) | 33.59 |
Quick Ratio | 2.80 |
Current Ratio | 3.06 |
ROA % (ttm) | 15.62 |
ROE % (ttm) | 23.57 |
ROIC % (ttm) | 35.28 |
Dividend Yield % | 7.37 |
Altman Z-Score | 4.55 |
CPHGF Number of Guru Trades
CPHGF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CPHGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CPHGF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Consun Pharmaceutical Group Ltd Insider Transactions
No Available Data
News about OTCPK:CPHGF
Total 0- 1